Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis Inc has shown a substantial increase in revenue from its India operations, with growth from $3 million in Q1 2025 to $12 million in Q2, and further rising to $15 million in Q3, indicating a strong market recovery and expansion. The company anticipates continued revenue growth in its India segment, supported by new contracts expected in the latter half of 2025 and into 2026. Additionally, the overall valuation of Aemetis appears attractive based on net present value (NPV) analysis, suggesting significant potential for upside from current share levels.

Bears say

Aemetis Inc. has reported significant declines in revenue for its fiscal Q2 and Q3 2025, leading to revised revenue estimates for 2025 and 2026, reflecting a downward adjustment from $270 million to $220 million and from $400 million to $330 million, respectively. The company has also noted negative earnings per share (EPS), with estimates being downgraded from $(1.37) to $(1.56) for 2025 and from $(0.46) to $(0.82) for 2026. Additionally, actual EPS results fell short of expectations, exacerbating concerns about the company's financial performance as it reported $(0.41) in Q2 compared to estimates and consensus figures.

Aemetis (AMTX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Feb 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.